Colinz Laboratories Declares Non-Applicability of SEBI Regulation 32 for Q4FY26
Colinz Laboratories Limited declared non-applicability of SEBI LODR Regulation 32 for Q4FY26 ended 31.03.2026. The regulation covers statement of deviation or variation for proceeds of public issue, rights issue, preferential issue, or QIP. The company confirmed it has not undertaken any such capital raising activities during the quarter, making the regulation non-applicable.
*this image is generated using AI for illustrative purposes only.
Colinz Laboratories Limited has officially declared the non-applicability of SEBI LODR Regulation 32 for the quarter ended 31.03.2026. The company communicated this regulatory update to BSE Limited through a formal declaration dated 3rd April, 2026.
Regulatory Declaration Details
The declaration specifically addresses Regulation 32 of The SEBI (LODR) Regulations, 2015, which deals with statement of deviation or variation for proceeds of various capital raising instruments. The company confirmed that this regulation does not apply to its operations for the specified quarter.
| Parameter | Details |
|---|---|
| Quarter Period | Ended 31.03.2026 |
| Declaration Date | 3rd April, 2026 |
| Regulation | SEBI LODR Regulation 32 |
| BSE Code | 531210 |
| CIN | L24200MH1986PLC041128 |
Reason for Non-Applicability
Colinz Laboratories stated that Regulation 32 is not applicable since the company has not undertaken any of the following activities during the quarter:
- Public issue
- Rights issue
- Preferential issue
- Qualified Institutional Placement (QIP)
Corporate Information
The declaration was signed by Vijaya Mani, Director of the company, bearing DIN: 11363910. The company maintains its corporate office at A/101, Pratik Estate, Next to Fortis Hospital, Mulund Link Road, Mumbai - 400 078, and can be contacted through multiple communication channels including email addresses colinzlabs@yahoo.com and colinzlabs@gmail.com .
This regulatory compliance declaration ensures transparency with stock exchanges and regulatory authorities regarding the company's capital structure activities during the quarter ended 31.03.2026.
Historical Stock Returns for Colinz Laboratories
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +4.78% | +5.93% | +4.81% | +19.54% | -17.51% | +421.65% |
Does Colinz Laboratories have any plans to raise capital through public or rights issues in the upcoming quarters of FY2027?
What factors might drive the company to consider a QIP or preferential issue for future expansion or debt reduction?
How will the company's current cash position and debt levels influence its capital raising strategy in the next fiscal year?
18
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
